Dr Nirmala Pathmanathan

Clinical Associate Professor
Westmead Clinical School


Map

Selected grants

2017

  • Using EHR data to drive translation of evidence into practice and improve cancer care provided by teams and individuals; Shaw T, Pathmanathan N; Cancer Institute NSW/Innovations in Cancer Control.

2016

  • A pilot study to develop novel targeted treatments and personalized tests for triple negative breast cancer; Graham J, Dinh P, Clarke C, Harnett P, Pathmanathan N; National Breast Cancer Foundation/Pilot Study Grants.

2010

  • Investigating the role of microRNAs in breast cancer progression; Soon P, Balleine R, Clarke C, Pathmanathan N; National Breast Cancer Foundation/Pilot Study Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Pathmanathan, N., McCart Reed, A., Kalaw, E., Nones, K., Bettington, M., Lim, M., Bennett, J., Johnstone, K., Kutasovic, J., Saunus, J., et al (2019). Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications. Journal of Pathology, 274(2), 214-227. [More Information]
  • Jacklyn, G., Morrell, S., McGeechan, K., Houssami, N., Irwig, L., Pathmanathan, N., Barratt, A. (2018). Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year. Breast, 37, 170-178. [More Information]
  • Wang, X., Mahajan, H., Dickinson, N., Cox, C., Byth, K., Bayly, A., Cahill, M., Pathmanathan, N. (2018). Fine needle aspiration biopsy cytology of phyllodes tumour and fibroadenoma: A cytomorphological study of 104 cases. Diagnostic Cytopathology, 46(11), 927-935. [More Information]
  • Soon, P., Provan, P., Kim, E., Pathmanathan, N., Graham, D., Clarke, C., Balleine, R. (2018). Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study. Clinical and Experimental Metastasis, 35(1-2), 3-13. [More Information]
  • Tay, T., Thike, A., Pathmanathan, N., Jara-Lazaro, A., Iqbal, J., Sng, A., Ye, H., Lim, J., Koh, V., et al (2018). Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer. Oncotarget, 9(14), 11619-11630. [More Information]
  • Pathmanathan, N., Geng, J., Li, W., Nie, X., Veloso, J., Wang, J., Hill, J., McCloud, P., Bilous, M. (2017). Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study. Asia-Pacific Journal of Clinical Oncology, 13(3), 249-260. [More Information]
  • Lorenzo, A., Pham, H., Zahid, A., Nguyen, B., Pathmanathan, N., Ctercteko, G., Hsu, J. (2017). Traumatic colonic injuries in Westmead Hospital - a paradigm shift in management over 10 years. Trauma, 19(4), 286-293. [More Information]
  • Ngui, N., French, J., Kilby, C., Pathmanathan, N., Elder, E. (2016). Axillary reverse mapping in patients with breast cancer: Is it oncologically safe? Journal of Surgical Oncology, 113(7), 726-731. [More Information]
  • Pathmanathan, N., Geng, J., Li, W., Nie, X., Veloso, J., Hill, J., McCloud, P., Bilous, M. (2016). Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study. Asia-Pacific Journal of Clinical Oncology, 12(4), 369-379. [More Information]
  • Pathmanathan, N., Renthawa, J., French, J., Elder, E., Hall, G., Mahajan, H., Teh, C., Bilous, M. (2014). Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology. ANZ Journal of Surgery, 84(10), 730-734. [More Information]
  • Pathmanathan, N., Balleine, R., Jayasinghe, U., Stalgis-Bilinski, K., Provan, P., Byth Wilson, K., Bilous, M., Salisbury, E., Boyages, J. (2014). The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. Journal of Clinical Pathology, 67(3), 222-228. [More Information]
  • Pathmanathan, N., Balleine, R. (2013). Ki67 and proliferation in breast cancer. Journal of Clinical Pathology, 66(6), 512-516. [More Information]
  • Pathmanathan, N., Provan, P., Mahajan, H., Hall, G., Byth Wilson, K., Bilous, M., Balleine, R. (2012). Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing. The Breast, 21(6), 724-729. [More Information]
  • Pathmanathan, N., Bilous, M. (2012). HER2 testing in breast cancer: An overview of current techniques and recent developments. Pathology, 44(7), 587-595. [More Information]
  • Pathmanathan, N., Albertini, A., Provan, P., Milliken, J., Salisbury, E., Bilous, M., Byth Wilson, K., Balleine, R. (2010). Diagnostic evaluation of papillary lesions of the breast on core biopsy. Modern Pathology, 23(7), 1021-1028. [More Information]
  • Balleine, R., Provan, P., Pupo, G., Pathmanathan, N., Cummings, M., Farshid, G., Salisbury, E., Bilous, M., Byth Wilson, K., kConFab Investigators., Mann, G. (2010). Familial Concordance of Breast Cancer Pathology as an Indicator of Genotype in Multiple-Case Families. Genes Chromosomes and Cancer, 49(12), 1082-1094. [More Information]
  • Pathmanathan, N., Ng, K., Peiris, M. (2009). On Estimation of Autoregressive Conditional Duration (ACD) Models Based on Different Error Distributions. Sri Lankan Journal of Applied Statistics, 10, 251-269.
  • Murali, R., Salisbury, E., Pathmanathan, N. (2006). Histiocytoid change in breast carcinoma - A report of 3 cases with an unusual cytomorphologic pattern of apocrine change. Acta Cytologica, 50(5), 548-552. [More Information]
  • Pathmanathan, N., Jones, W., Salisbury, E., Bilous, M. (2006). Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: Initial experience and lessons learnt in establishing a new practice. Pathology, 38(4), 321-327. [More Information]
  • Thiagalingam, A., Pouliopoulos, J., Barry, M., Salisbury, E., Pathmanathan, N., Boyd, A., Ross, D., Kovoor, P. (2005). A thermochromic dispersive electrode can measure the underlying skin temperature and prevent burns during radiofrequency ablation. Journal of Cardiovascular Electrophysiology, 16(7), 781-788. [More Information]
  • Pathmanathan, N., Murali, R. (2003). Composite phaeochromocytoma with intra-tumoural metastatic squamous cell carcinoma [3]. Pathology, 35(3), 263-265. [More Information]

2019

  • Pathmanathan, N., McCart Reed, A., Kalaw, E., Nones, K., Bettington, M., Lim, M., Bennett, J., Johnstone, K., Kutasovic, J., Saunus, J., et al (2019). Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications. Journal of Pathology, 274(2), 214-227. [More Information]

2018

  • Jacklyn, G., Morrell, S., McGeechan, K., Houssami, N., Irwig, L., Pathmanathan, N., Barratt, A. (2018). Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year. Breast, 37, 170-178. [More Information]
  • Wang, X., Mahajan, H., Dickinson, N., Cox, C., Byth, K., Bayly, A., Cahill, M., Pathmanathan, N. (2018). Fine needle aspiration biopsy cytology of phyllodes tumour and fibroadenoma: A cytomorphological study of 104 cases. Diagnostic Cytopathology, 46(11), 927-935. [More Information]
  • Soon, P., Provan, P., Kim, E., Pathmanathan, N., Graham, D., Clarke, C., Balleine, R. (2018). Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study. Clinical and Experimental Metastasis, 35(1-2), 3-13. [More Information]
  • Tay, T., Thike, A., Pathmanathan, N., Jara-Lazaro, A., Iqbal, J., Sng, A., Ye, H., Lim, J., Koh, V., et al (2018). Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer. Oncotarget, 9(14), 11619-11630. [More Information]

2017

  • Pathmanathan, N., Geng, J., Li, W., Nie, X., Veloso, J., Wang, J., Hill, J., McCloud, P., Bilous, M. (2017). Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study. Asia-Pacific Journal of Clinical Oncology, 13(3), 249-260. [More Information]
  • Lorenzo, A., Pham, H., Zahid, A., Nguyen, B., Pathmanathan, N., Ctercteko, G., Hsu, J. (2017). Traumatic colonic injuries in Westmead Hospital - a paradigm shift in management over 10 years. Trauma, 19(4), 286-293. [More Information]

2016

  • Ngui, N., French, J., Kilby, C., Pathmanathan, N., Elder, E. (2016). Axillary reverse mapping in patients with breast cancer: Is it oncologically safe? Journal of Surgical Oncology, 113(7), 726-731. [More Information]
  • Pathmanathan, N., Geng, J., Li, W., Nie, X., Veloso, J., Hill, J., McCloud, P., Bilous, M. (2016). Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study. Asia-Pacific Journal of Clinical Oncology, 12(4), 369-379. [More Information]

2014

  • Pathmanathan, N., Renthawa, J., French, J., Elder, E., Hall, G., Mahajan, H., Teh, C., Bilous, M. (2014). Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology. ANZ Journal of Surgery, 84(10), 730-734. [More Information]
  • Pathmanathan, N., Balleine, R., Jayasinghe, U., Stalgis-Bilinski, K., Provan, P., Byth Wilson, K., Bilous, M., Salisbury, E., Boyages, J. (2014). The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. Journal of Clinical Pathology, 67(3), 222-228. [More Information]

2013

  • Pathmanathan, N., Balleine, R. (2013). Ki67 and proliferation in breast cancer. Journal of Clinical Pathology, 66(6), 512-516. [More Information]

2012

  • Pathmanathan, N., Provan, P., Mahajan, H., Hall, G., Byth Wilson, K., Bilous, M., Balleine, R. (2012). Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing. The Breast, 21(6), 724-729. [More Information]
  • Pathmanathan, N., Bilous, M. (2012). HER2 testing in breast cancer: An overview of current techniques and recent developments. Pathology, 44(7), 587-595. [More Information]

2010

  • Pathmanathan, N., Albertini, A., Provan, P., Milliken, J., Salisbury, E., Bilous, M., Byth Wilson, K., Balleine, R. (2010). Diagnostic evaluation of papillary lesions of the breast on core biopsy. Modern Pathology, 23(7), 1021-1028. [More Information]
  • Balleine, R., Provan, P., Pupo, G., Pathmanathan, N., Cummings, M., Farshid, G., Salisbury, E., Bilous, M., Byth Wilson, K., kConFab Investigators., Mann, G. (2010). Familial Concordance of Breast Cancer Pathology as an Indicator of Genotype in Multiple-Case Families. Genes Chromosomes and Cancer, 49(12), 1082-1094. [More Information]

2009

  • Pathmanathan, N., Ng, K., Peiris, M. (2009). On Estimation of Autoregressive Conditional Duration (ACD) Models Based on Different Error Distributions. Sri Lankan Journal of Applied Statistics, 10, 251-269.

2006

  • Murali, R., Salisbury, E., Pathmanathan, N. (2006). Histiocytoid change in breast carcinoma - A report of 3 cases with an unusual cytomorphologic pattern of apocrine change. Acta Cytologica, 50(5), 548-552. [More Information]
  • Pathmanathan, N., Jones, W., Salisbury, E., Bilous, M. (2006). Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: Initial experience and lessons learnt in establishing a new practice. Pathology, 38(4), 321-327. [More Information]

2005

  • Thiagalingam, A., Pouliopoulos, J., Barry, M., Salisbury, E., Pathmanathan, N., Boyd, A., Ross, D., Kovoor, P. (2005). A thermochromic dispersive electrode can measure the underlying skin temperature and prevent burns during radiofrequency ablation. Journal of Cardiovascular Electrophysiology, 16(7), 781-788. [More Information]

2003

  • Pathmanathan, N., Murali, R. (2003). Composite phaeochromocytoma with intra-tumoural metastatic squamous cell carcinoma [3]. Pathology, 35(3), 263-265. [More Information]

To update your profile click here. For support on your academic profile contact .